Pacira BioSciences Market Sentiment

SPY774.46+0.07%QQQ747.75+0.02%BTC/USD82,210.39+0.63%DIA511.79+0.03%GLD379.46+0.22%TLT77.66−0.27%

Premium

Pacira BioSciences Inc

PCRXNASDAQ

Trade with Public

$36.39

11.1944.4%

Last update: Oct 8, 7:59 PM

$36.37

11.1744.33%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

PRO

Why Is It Moving?™:Pacira BioSciences shares are trading higher after the company announced it...

M&A: Pacira BioSciences (PCRX) announced it will be acquired by Viatris (VTRS) on Thursday, October 8, 2026 for $1.7B

Pacira BioSciences Market Sentiment - Benzinga

Pacira BioSciences Market Sentiment

Market sentiment signals for Pacira BioSciences (PCRX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 27.3% short float

Options Flow▼ 1.20 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

16 analysts

Options Flow (P/C)

1.20

More puts — Bearish

2,430 calls · 2,917 puts

Avg Consensus PT

$36

-0.2%

Highest Price Target

$65

+78.7%

HC Wainwright & Co.

Lowest Price Target

$18

-50.5%

RBC Capital

Short Interest

27.3%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	JP Morgan	Hardik Parikh—	+0.4%	$37	Upgrade	Underweight→Neutral
Oct 8, 2026	Jefferies	Glen Santangelo—	-1.0%	$36	Downgrade	Buy→Hold
Oct 8, 2026	Needham	Serge Belanger—	—	—	Downgrade	Buy→Hold
Oct 7, 2026	Truist Securities	Les Sulewski—	-14.8%	$30 → $31	Maintained	Buy
Sep 23, 2026	Oppenheimer	Les Sulewski—	-12.0%	$32	Initiate	Outperform
Sep 9, 2026	Leerink Partners	Daniel Clark—	-23.0%	$28	Initiate	Market Perform
Aug 5, 2026	RBC Capital	Douglas Miehm—	-31.3%	$24 → $25	Maintained	Sector Perform
Aug 5, 2026	Needham	Serge Belanger—	-9.3%	$32 → $33	Maintained	Buy
Jul 1, 2026	HC Wainwright & Co.	Douglas Tsao—	+4.5%	$38 → $38	Maintained	Buy
May 1, 2026	RBC Capital	Douglas Miehm—	-34.0%	$22 → $24	Maintained	Sector Perform
May 1, 2026	Needham	Serge Belanger—	-12.0%	$30 → $32	Maintained	Buy
Mar 26, 2026	Barclays	Glen Santangelo—	-31.3%	$27 → $25	Maintained	Equal-Weight
Jan 9, 2026	HC Wainwright & Co.	Douglas Tsao—	+4.5%	$38 → $38	Maintained	Buy
Jan 9, 2026	Needham	Serge Belanger—	-17.5%	$30 → $30	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	-25.8%	$27	Initiate	Equal-Weight
Nov 17, 2025	HC Wainwright & Co.	Douglas Tsao—	+4.5%	$38	Assumes	Buy
Nov 7, 2025	Truist Securities	Les Sulewski—	-23.0%	$30 → $28	Maintained	Buy
May 9, 2025	Needham	Serge Belanger—	-17.5%	$32 → $30	Maintained	Buy
Apr 8, 2025	Needham	Serge Belanger—	-12.0%	$32 → $32	Maintained	Buy
Apr 8, 2025	HC Wainwright & Co.	Oren Livnat—	+78.7%	$48 → $65	Maintained	Buy
Feb 28, 2025	Barclays	Balaji Prasad—	-34.0%	$17 → $24	Maintained	Overweight
Feb 28, 2025	Needham	Serge Belanger—	-12.0%	$30 → $32	Maintained	Buy
Feb 28, 2025	HC Wainwright & Co.	Oren Livnat—	+92.5%	$57 → $70	Maintained	Buy
Jan 30, 2025	Truist Securities	Les Sulewski—	-31.3%	$8 → $25	Upgrade	Sell→Hold
Jan 14, 2025	RBC Capital	Gregory Renza—	-50.5%	$18 → $18	Maintained	Sector Perform